Ionis Pharmaceuticals, Inc. Convertible Notes Payable, Noncurrent
Ionis Pharmaceuticals, Inc. (IONS) had Convertible Notes Payable, Noncurrent of $146.03 million as of 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleLongTermNotesPayable · last filed 2013-02-28
- 2012-06-30: Convertible Notes Payable, Noncurrent $146.03M.
- 2012-03-31: Convertible Notes Payable, Noncurrent $143.72M.
- 2011-12-31: Convertible Notes Payable, Noncurrent $141.45M.
- 2011-09-30: Convertible Notes Payable, Noncurrent $139.24M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2012-06-30 | $146.03M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $143.72M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $141.45M 10-K · filed 2013-02-28 |
| 2011-09-30 | $139.24M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $137.07M 10-Q · filed 2011-08-08 |
| 2011-03-31 | $134.96M 10-Q · filed 2011-05-06 |
| 2010-12-31 | $132.90M 10-K · filed 2012-02-29 |
| 2010-09-30 | $130.88M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $128.91M 10-Q · filed 2010-08-09 |
| 2009-12-31 | $125.10M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |